Introduction to how to purchase lorlatinib through formal channels in China

Lorlatinib, also known as lorlatinib, is a third-generation ALK/ROS1 targeted inhibitor, mainly used to treat ALK positivity Patients with non-small cell lung cancer (NSCLC), especially those who have developed drug resistance after receiving other ALK inhibitors (such as crizotinib, ceritinib, alectinib). This drug has unique clinical advantages due to its good penetration ability into brain metastases. At present, lorlatinib has been officially approved for marketing in mainland China and has been included in the national medical insurance directory, providing patients with a more standardized and accessible treatment path.

If patients want to purchase lorlatinib through regular channels, they should first go to a tertiary hospital or cancer specialist hospital with qualifications for lung cancer diagnosis and treatment for diagnosis and evaluation. The doctor will decide whether lorlatinib is suitable for use based on pathological classification, genetic testing reports and treatment history. After diagnosis, the doctor will issue a prescription, and the patient can go to the hospital pharmacy or a designated medical insurance designated pharmacy to buy medicines with the prescription. Due to the high price of the drug, part of the cost can be reimbursed according to the local medical insurance policy after being included in the medical insurance. You need to consult the local medical insurance department or hospital pharmacist for the reimbursement ratio, threshold and cap line.

In the domestic market, the price of lorlatinib is generally around 10,000 to 20,000 yuan per box. The specific price is related to the purchase channel, specifications and medical insurance coverage. Although it is covered by medical insurance, because it is an imported original drug, the patient still needs to pay part of the cost after medical insurance reimburses it. If some patients require long-term medication, it is recommended to communicate with their attending physician to see if there are drug assistance programs or charity projects that they can apply for to relieve financial pressure.

In addition to the regular purchase channels in mainland China, there are also foreign versions of lorlatinib circulating on the market, including original drugs and generic drugs. For example, the price of the Turkish version of the original drug is relatively low, about RMB 7,000 per box, while the price of the original drug in Hong Kong, China, is higher, reaching about RMB 3 yuan. In addition, generic drugs from Laos and Bangladesh have attracted the attention of some patients due to their low prices (about 1,000yuan per box). Their ingredients are basically the same as the original drugs, but legality and customs clearance risks require special attention. It is recommended that patients give priority to purchasing drugs through formal domestic channels to ensure drug quality and medication safety, and never purchase drugs on their own through unknown online platforms to avoid medication risks.

Reference materials:https://www.drugs.com/